Incidence of second primary malignancies in patients with esophageal cancer: A comprehensive review

Current Medical Research and Opinion

Volumn 29, Issue 9, 2013, Pages 1055-1065

  Nandy, Nina ^a   Dasanu, Constantin A ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Medical Oncology and Blood Disorders   (United States)

Author keywords

Chemoprevention; Esophageal cancer; Prognosis; Second primary malignancy

Indexed keywords

ANTINEOPLASTIC AGENT;

ALCOHOL CONSUMPTION; BREAST CANCER; BRONCHUS CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHEMOPROPHYLAXIS; DISEASE PREDISPOSITION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ETHNICITY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; KIDNEY CANCER; LUNG CANCER; NONHUMAN; OBESITY; OROPHARYNX CANCER; RETROSPECTIVE STUDY; REVIEW; SECOND CANCER; SMOKING; STOMACH CANCER; THYROID CANCER;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; NEOPLASMS, SECOND PRIMARY; ORGAN SPECIFICITY; RISK FACTORS;

EID: 84882778999     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.816276     Document Type: Review

References (60)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108
2. DeMeester SR. Epidemiology and biology of esophageal cancer. Gastrointest Cancer Res 2009;3:S1-5
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96
4. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50
5. Steevens J, Schouten LK, Goldbohm RA, et al. Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Int J Cancer 2011;129:2681-93
6. Kamangar F, Chow WH, Abet C, et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009;38:27-vii
7. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011;365:1375-83
8. Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: A systematic review and meta-analysis. Am J Epidemiol 2008;168:237-49
9. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: A metaanalysis. Cancer Prev Res 2008;1:329-38
10. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349: 2241-52
11. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4:85-92
12. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009;24:729-35
13. Matsubara T, Yamada K, Nakagawa A. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:4336-41
14. Shibuya H, Wakita T, Nakagawa T, et al. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer 1995; 76:101-5
15. Poon R, Law S, Chu K, et al. Multiple primary cancers in esophageal squamous cell carcinoma: Incidence and implications. Ann Thorac Surg 1998;65:1529-34
16. Fogel TD, Harrison LB, Son YH. Subsequent upper aerodigestive malignancies following treatment of esophageal cancer. Cancer 1985;55:1882-85
17. Goodner J, Watson W. Cancer of the esophagus. Cancer 1956;9:1248-52
18. Bosch A, Frias Z, Caldwell W, et al. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol 1979;18:103-12
19. Shibuya H, Takagi J, Horiuchi S, et al. Carcinoma of the esophagus with synchronous or metachronous primary carcinomas in other organs. Acta Radiol Oncol 1982;21:39-43
20. Takita H, Vincent RG, Caicedo V, et al. Squamous cell carcinoma of the esophagus: A study of 153 cases. J Surg Oncol 1977;9:547-54
21. Van Rees BP, Cleton-Jansen AM, Cense HA, et al. Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract. Hum Pathol 2000;31:269-71
22. Strong MS, Incze J, Vaughan LW. Field cancerization in the aerodigestive tract - its etiology, manifestation and significance. J Otolaryngol 1984; 13:1-6
23. Wynder EL, Dodo H, Bloch DA, et al. Epidemiologic investigation of multiple primary cancer of the upper alimentary and respiratory tracts. Cancer 1969;24:730-9
24. Schottenfield D, Gantt RC, Wynder EL. The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx, and lung: A prospective study. Prev Med 1974;3:277-93
25. Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004;108:741-9
26. Engeland A, Bjorge T, Haldorsen T, et al. Use of multiple primary cancers to indicate associations between smoking and cancer incidence: An analysis of 500,000 cancer cases diagnosed in Norway during 1953-1993. Int J Cancer 1997;70:401-7
27. Morita M, Kuwano H, Ohno S, et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: Reference to smoking, drinking and family history. Int J Cancer 1994;58:207-10
28. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review. Int J Cancer 1996;69:225-35
29. Leung WK, To KF, Ng YP, et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer 2001;84:335-9
30. Mori T, Miura K, Aoki T, et al. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994:54:3396-7
31. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-83
32. Shi X, Liu L, Din Q. A study on the CD(4) (+) CD (25) (+) regulatory T cells in patients with gastrointestinal malignancies. Med Oncol 2009;4:471-5
33. Somja J, Demoulin S, Roncarati P, et al. Dendritic cells in Barrett's esophagus carcinogenesis: An inadequate microenvironment for antitumor immunity? Am J Pathol 2013;182:2168-79
34. Vaittinen P, Hemminki K. Risk factors and age-incidence relationships for contra lateral breast cancer. Int J Cancer 2000;88:998-1002
35. Shureiqi I, Cooksley CD, Morris J, et al. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst 2001;93:1264-6
36. Levi F, Randimbison L, Maspoli M, et al. Second neoplasms after oesophageal cancer. Int J Cancer 2007;121:694-7
37. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211
38. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:872-8
39. Das A, Thomas S, Zablotska LB, et al. Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol 2006;40:405-11
40. Yang DH, Jung HY. Treatment of esophageal cancer. Korean J Gastroenterol 2008;25:338-50
41. Manavoglu O, Orhan B, Evrensel T, et al. Second primary cancer due to radiotherapy and chemotherapy. J Environ Pathol Toxicol Oncol 1996;15:275-8
42. Zhu G, Chen Y, Zhu Z, et al. Risk of second primary cancer after treatment for esophageal cancer: A pooled analysis of nine cancer registries. Dis Esophagus 2012;25:505-11
43. Chaung S, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: A pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 2008;17:1543-9
44. Abo S, Miura H, Kudo T, et al. Concurrent cancer of the esophagus and other organ in Japan. Jpn J Gastroenterol Surg 1980;13:377-81
45. Kagei K, Hosokawa M, Shirato H, et al. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 2002;32:120-7
46. Koide N, Yazawa K, Koike S, et al. Oesophageal cancer associated with other primary cancers: A study of 131 patients. J Gastroenterol Hepatol 1997;12:690-4
47. Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134:29-38
48. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: Meta-analysis of the randomized trials. J Natl Cancer Inst 2009;101:256-66
49. Flossman E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet 2007;369:1603-13
50. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20 year follow-up of five randomised trials. Lancet 2010;376:1741-50
51. Rothwell PM, Fowkes FGR, Belch JFF, et al. Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials. Lancet 2011;377:31-41
52. Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nature Reviews Clin Oncol 2012;9:259-67
53. Zimmerman KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999;59:198-204
54. Carlton PS, Kresty LA, Siglin JC, et al. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 2001;22:441-6
55. Chen T, Yan F, Qian J, et al. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res 2011;5:41-50
56. Kresty LA, Frankel WL, Hammond CD, et al. Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: Interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients. Nutr Cancer 2006;54:148-56
57. Kumagai Y, Kawano T, Nakajima Y. Multiple primary cancers associated with esophageal caricinoma. Surg Today 2001;31:872-6
58. Nagasawa S, Onda M, Sasajima K, et al. Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 2000;13: 226-30
59. Ono K, Takenaka M, Yokoyama E, et al. Clinical analysis of esophageal cancer associated with other primary cancers. Kyobu Geka 2011;64:93-6
60. Van Westreenen H, Westerterp M, Jager P, et al. Synchronous primary neoplasms detected on 18F-FDG PET staging of patients with esophageal cancer. J Nuclear Med 2005;46:1321-5